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H2AX phosphorylation at serine 139 (H2AX) is a sensitive indicator of both DNA damage and DNA replication stress.
Here we show that H2AX formation is greatly enhanced in response to replication inhibitors but not ionizing radiation
in HCT116 or SW480 cells depleted of Chk1. Although H2AX phosphorylation precedes the induction of apoptosis in such
cells, our results suggest that cells containing H2AX are not committed to death. H2AX foci in these cells largely
colocalize with RPA foci and their formation is dependent upon the essential replication helicase cofactor Cdc45,
suggesting that H2AX phosphorylation occurs at sites of stalled forks. However Chk1-depleted cells released from
replication inhibitors retain H2AX foci and do not appear to resume replicative DNA synthesis. BrdU incorporation only
occurs in a minority of Chk1-depleted cells containing H2AX foci after release from thymidine arrest and, in cells
incorporating BrdU, DNA synthesis does not occur at sites of H2AX foci. Furthermore activated ATM and Chk2 persist
in these cells. We propose that the H2AX foci in Chk1-depleted cells may represent sites of persistent replication fork
damage or abandonment that are unable to resume DNA synthesis but do not play a direct role in the Chk1 suppressed
death pathway.
INTRODUCTION
The orderly and precise replication of cellular DNA is es-
sential to maintain genome stability. Therefore, cells re-
spond to disruptions of DNA replication by protecting the
integrity of stalled forks, suppressing the firing of new rep-
lication origins, and initiating repair. Considerable evidence
has accumulated that the PIK-like kinase Ataxia telangiec-
tasia–mutated and Rad3–related (ATR) and its downstream
phosphorylation target Chk1 are crucial for this response
(Cimprich and Cortez, 2008). Inhibition of DNA replication
in many cell types leads to ssDNA formation that appears to
be a result of the continued unwinding of DNA by the
helicase complex in the absence of replication progression
(Byun et al., 2005). These ssDNA regions become coated with
RPA that, in turn, interact with the ATR-interacting protein
(ATRIP) and ATR (Zou and Elledge, 2003; Ball et al., 2005).
The formation of this complex is necessary for efficient phos-
phorylation and activation of Chk1 (Zou and Elledge, 2003)
although Chk1 also may be phosphorylated by ATR where
ATR-ATRIP complex does not bind to RPA (Ball et al., 2005).
Activated Chk1 coordinates many of the cellular responses
to replication fork stress. More specifically, it prevents the
inappropriate firing of late replication origins, abandonment
of replication forks, and premature chromosome condensa-
tion after disruption of replication (Feijoo et al., 2001;
Nghiem et al., 2001; Zachos et al., 2003; Maya-Mendoza et al.,
2007). It has also been reported that Chk1 activation is
required for homologous recombination (HR)-mediated re-
start of replication forks stalled by replication inhibitors
(Sorensen et al., 2005).
More recently Chk1 has been shown to play a key role in
protecting cells from apoptosis in response to many types of
DNA damage (Rodriguez and Meuth, 2006; Sidi et al., 2008).
p53-deficient tumor cells depleted of Chk1 show an en-
hanced level of apoptosis in response to ionizing radiation
(IR; Sidi et al., 2008). This death pathway is caspase-2–de-
pendent and requires both Ataxia telangiectasia mutated
(ATM) and ATR. Chk1 also suppresses apoptosis induced
by DNA replication inhibitors. When Chk1 is depleted, rep-
lication inhibitors trigger death in S-phase cells in a caspase-
3–dependent manner (Rodriguez and Meuth, 2006; Myers et
al., 2009). However the death response to replication inhib-
itors is independent of p53 status (Rodriguez and Meuth,
2006) and does not require ATM or ATR function (Myers et
al., 2009). Previous work from our group has shown that
apoptosis induced by replication inhibitors in Chk1-de-
pleted cells can be suppressed by depletion of the essential
replication helicase cofactor Cdc45 and is enhanced in p21-
deficient cells, indicating that events tied to DNA replication
integrity or origin firing in the absence of Chk1 may be key
to triggering this death response (Rodriguez and Meuth,
2006; Rodriguez et al., 2008). Other reports have indicated
that the variant histone core protein H2AX is phosphory-
lated at serine 139 after treatment with a Chk1 inhibitor,
particularly in the presence of agents that inhibit DNA rep-
lication (Syljuasen et al., 2005; Ewald et al., 2007). This phos-
phorylated form of H2AX (called H2AX) has mostly been
studied in association with DSB formation (Rogakou et al.,
1998). H2AX appears within minutes of IR-induced DNA
double-strand break (DSB) formation through the action of
ATM and DNA-activated protein kinase (DNA-PK) activi-
ties (Stiff et al., 2005). H2AX is distributed over a megabase
swath of DNA surrounding a DSB to form H2AX foci
(Rogakou et al., 1999) and plays a key role in the recruitment
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of DNA repair and signaling factors to the site of damage, in
some cases through physical interactions with the proteins
(Paull et al., 2000; Stucki et al., 2005). H2AX-deficient cells are
IR-sensitive, show impaired repair of DSBs, and exhibit
chromosome instability (Celeste et al., 2002). H2AX can also
be detected in cells at later stages of apoptosis during DNA
fragmentation (Rogakou et al., 2000) and has been reported
to be required for this fragmentation but not for caspase-3
activation (Lu et al., 2006).
In the work reported here we investigated the role of
H2AX phosphorylation in the Chk1 suppressed apoptotic
pathway responding to DNA replication stress. We show an
enhanced level of H2AX in Chk1-depleted cells exposed to
replication inhibitors that can persist even when cells are
shifted to normal medium. Our data indicate that Chk1-
depleted cells retaining H2AX are less likely to succumb to
apoptosis after replication stress although H2AX does not
appear to facilitate the restart of stalled replication forks or
reentry into the cell cycle.
MATERIALS AND METHODS
Cell Lines and Cultures
The HCT116 and SW480 human colon cancer cell lines were obtained from
American Type Culture Collection (Manassas, VA), and the p21 derivative of
HCT116 cell line was provided by Dr. Bert Vogelstein (Johns Hopkins Uni-
versity, Baltimore, MD). The immortalized human fibroblast cell line MRC5
VA was obtained form the CRUK London Laboratories Cell Repository.
Cells were maintained in DMEM supplemented with 10% fetal bovine
serum (FBS). For experiments using thymidine, dialyzed FBS was used to
remove deoxynucleosides in the serum that might interfere in the response to
this agent. Replication inhibitors thymidine and hydroxyurea (HU) were used
at a concentration 2 mM. For some experiments cells were irradiated using a
CIS IBL 437 Cs-137 irradiator. In some experiments a chemical inhibitor of
Chk1 activity (Gö6976, Calbiochem, La Jolla, CA; Kohn et al., 2003) was used
at concentrations 0.1 or 1 M. The inhibitor was added to cell cultures 1 h
before treatment with replication inhibitors.
Small Interfering RNA Transfection
The Chk1 small interfering RNA (siRNA) was designed by J. Blackburn and
C. Smythe, having the following sequence (sense strand: GAAGCAGUCG-
CAGUGAAGA). For Cdc45 depletion two different sets of siRNAs were used.
The first set (L-003232-00; Dharmacon, Lafayette, CO) consisted of a pool of
four small interfering RNA (siRNA) doublexes with the following sense
sequences: GUCAAUGUAUACAACGAUAUU, CGUCAGCCAUGGUGAU-
GUUUU, UCACUCAAAUGAAAUACGUUU, and GCAAAGAGUUCUAC-
GAGGUUU. The second set (HSS112144, HSS112145, and HSS112146; Invitro-
gen, Paisley, United Kingdom) consisted of a pool of three stealth siRNA
doublexes with the following sense sequences: GACGUGGUCUUUGCCAC-
CAUGUCUU, GGCACUCCAGAUGUCAUGCUGUUCU, and GACAGCCU-
GUGCAACACCAGCUAUA.
Control siRNAs, containing nonspecific sequences that do not have homol-
ogy in human genome, were provided by Eurogentec (Hythe Southampton,
Hampshire, United Kingdom; OR-0030-NEG) or Invitrogen (Stealth siRNA
Negative control 12935-400). siRNA and/or Stealth siRNA duplexes were
transfected into cells using Lipofectamine 2000 (Invitrogen) according to
manufacturer’s instructions. The cells were then incubated for 24 h before
further treatment.
Cell Cycle Analysis
Cell cycle analysis of floating and adherent cells was performed as described
previously (Rodriguez and Meuth, 2006).
Detection of Apoptosis
In Vivo Detection of Caspase-3 Activation versus Cell Cycle. After appro-
priate treatments, floating and adherent cells (obtained from the medium and
a PBS wash or after trypsinization, respectively) were pooled and pelleted by
centrifugation. Cell pellets were washed with PBS and assayed for active
caspase-3, using the CaspGLOW fluorescein active caspase-3 kit according to
the manufacturer’s instructions (MBL, Woburn, MA). Cells were then
costained with propidium iodide (PI) by resuspension in PBS containing 5
g/ml PI, 100 g/ml RNAse A and 0.1% (vol/vol) Triton X-100. After 30-min
incubation, stained nuclei were analyzed on a FACsCalibur (BD Biosciences,
Franklin Lakes, NJ) using Cell Quest software.
TUNEL Assay. Floating and adherent cells (obtained as described above)
were assayed for terminal deoxynucleotidytransferase dUTP nick end label-
ing (TUNEL), using the APO-BRDU kit according to the manufacturer’s
instructions (BD PharMingen, San Diego, CA). Stained nuclei were analyzed
by flow cytometry.
Flow Cytometric Analysis of H2AX
Pellets of floating and adherent cells were washed with PBS, fixed in 70%
ice-cold ethanol, and stored at 20°C for up to 2 wk. After two washes with
PBS, cells were incubated for 15 min on ice in hybridization buffer (PBS
containing 0.5% bovine serum albumin [BSA] and 0.25% Triton X-100). After
centrifugation, cells were hybridized with an Alexa 488–conjugated rabbit
monoclonal anti- H2AX antibody (Cell Signaling, Beverly, MA; 9719) diluted
at a ratio of 1:10 in hybridization buffer, and incubated for 1 h in the dark at
room temperature (RT). Cells were then rinsed twice with PBS containing
0.25% Triton X-100 and stained with PI solution (PBS containing 5 g/ml PI,
100 g/ml RNAse A) for 30 min before flow cytometry.
Immunofluorescence Analysis
For H2AX foci staining, cells were grown on glass coverslips, treated as
indicated, fixed with 3% buffered paraformaldehyde for 15 min at RT, and
permeabilized in PBS containing 0.5% Triton X-100 for 8 min at RT. Cells were
then incubated with 1:500 diluted polyclonal anti-H2AX antibody (Cell
Signaling; 2577) for 45 min at RT and detected with a secondary Alexa
488–conjugated goat anti-rabbit IgG (A11008; Molecular Probes, Invitrogen,
Eugene, OR). Antibody dilutions and washes after incubations were per-
formed in PBS containing 0.5% BSA and 0.05% Tween 20. Coverslips were
finally mounted in Vectashield mounting medium with DAPI (H-1500; Vector
Laboratories, Burlingame, CA).
For simultaneous analysis of TUNEL cells and H2AX, cells were cul-
tured, fixed, and permeabilized as described above. Then, the TUNEL assay
was performed according to the manufacturer’s instructions (ApoAlert DNA
Fragmentation Assay Kit; Clontech, A Takara Bio, Palo Alto, CA). At the end
of this assay, cells were washed with PBS containing 0.25% Triton X-100 for 5
min at RT and further stained with the anti-H2AX antibody specified above
for 45 min, followed by a 30-min staining with a secondary Alexa 594–
conjugated goat anti-rabbit IgG (A110012; Molecular Probes, Invitrogen). For
simultaneous detection of H2AX and the activated form of caspase-3, cells
were cultured on glass coverslips and treated with siRNAs and replication
inhibitor according to standard procedures. At the end of the treatments, cells
washed twice with PBS and incubated with the FITC-conjugated caspase-3
inhibitor DEVD-FMK (CaspGLOW fluorescein active caspase-3 kit; MBL,
Woburn, MA), at a dilution of 1:300, at 37°C for 1 h. They were then washed
twice with PBS and fixed, permeabilized, and stained for H2AX as described
above.
For double staining of H2AX with RPA, cells were preextracted with
PHEM buffer (45 mM HEPES, pH 6.9, 45 mM PIPES, pH 6.9, 10 mM EGTA,
pH 7.0, 5 mM MgCl2) containing 0.1% Triton X-100 and 1 mM PMSF for 1min
at RT before being fixed, permeabilized, and stained as described above. For
RPA detection, mouse anti-RPA34 (NA19L; Calbiochem) was used at a dilu-
tion of 1:500 and detected with a secondary Alexa-594–conjugated goat
anti-mouse IgG (A11005; Molecular Probes, Invitrogen).
Immunofluorescence was visualized using a Nikon Eclipse T200 inverted
microscope (Melville, NY), equipped with a Hamamatsu Orca ER camera
(Bridgewater, NJ) and a 200 W metal arc lamp (Prior Scientific, Cambridge,
United Kingdom), with a 100 objective. Images were captured as wide-field
acquisitions, analyzed by Volocity 3.6.1 software (Improvision, Coventry,
United Kingdom) and further processed with ImageJ software (http://rsbweb.
nih.gov/ij/). At least 300 cells were analyzed for each individual experiment,
and experiments were repeated twice. In experiments where the fraction of
colocalized foci were measured, HCT116 Chk1-depleted cells treated for 6 h
with thymidine were used (after longer exposures to thymidine the H2AX
signal becomes considerably diffused). At least 100 cells were analyzed from
wide-field acquisition overlays. The colocalization factor was defined as pre-
viously described by Sengupta et al. (2004): [(fraction of cells having colocal-
ization)  (fraction of foci colocalized per cell)]  100.
Detection of Bromodeoxyuridine Incorporation
Pulse Labeling. Untreated cells or cells exposed to thymidine were washed
thoroughly with thymidine-free medium and cultured in fresh medium con-
taining 10 M bromodeoxyuridine (BrdU; Sigma-Aldrich) for 1 h. Cells were
then harvested directly or left to grow in BrdU-free medium for varying
lengths of time before harvest.
BrdU Staining for Flow Cytometric Analysis. Cell pellets were washed with
PBS, fixed in 70% ice-cold ethanol, and stored at 20°C for up 2 wk. To
denature DNA, fixed cells were resuspended in 2N HCl and incubated for 30
min at RT. After thoroughly washing with PBS, to remove any acid traces,
cells were hybridized with a mouse monoclonal anti-BrdU antibody (Dako-
Cytomation, Carpinteria, CA; M0744) diluted at a ratio of 1:50 in PBST (PBS
containing 0.1% BSA and 0.2% Tween 20, pH 7.4) and incubated for 20 min at
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RT. Cells were then rinsed with PBS containing 0.2% Tween 20 and incubated
with FITC-conjugated rabbit anti-mouse immunoglobulin antibody (DakoCy-
tomation; F0313) diluted at a ratio of 1:10 in PBST. After 20-min incubation at
RT in the dark, cells were washed with PBS and stained with PI solution for
30 min before flow cytometry.
BrdU Staining for Microscopic Analysis. Cells were cultured, fixed, and
permeabilized according to standard protocol, as described above. Cells were
then treated with 100 U/ml DNase (Promega, Madison, WI; M6101) for 30
min at RT. After that, cells were incubated with the above mouse anti-BrdU
simultaneously with a rabbit anti-H2AX antibody (Cell Signaling; 2577), for
double labeling with H2AX, or with a rat anti-RPA34 antibody (Cell Signal-
ing; 2208), for double labeling with RPA34. Primary antibodies were detected
with a secondary goat anti-mouse Alexa594 (A11005; Molecular Probes, In-
vitrogen) and an Alexa 488–conjugated goat anti-rabbit IgG (A11008; Molec-
ular Probes, Invitrogen) or an Alexa 488–conjugated goat anti-rat IgG
(A11006; Molecular Probes, Invitrogen).
Protein Extraction and Western Blotting
Whole-cell extracts were prepared and fractionated by SDS-PAGE before
being blotted onto nitrocellulose (Whatman Schleicher & Schuell, Dassel,
Germany) as described previously (Bolderson et al., 2004). Proteins were
detected with the ECL detection system (GE Healthcare, Little Chalfont,
Buckinghamshire, United Kingdom) using the following specific antibodies:
H2AX (2577; Cell Signaling), Chk1 (2360; Cell Signaling), -actin (A-5060;
Sigma-Aldrich), RPA34 (NA19L; Calbiochem), cleaved caspase-3 (ab32042;
Abcam, Cambridge, United Kingdom), Cdc45 (sc-20685; Santa-Cruz Biotech-
nology, Santa-Cruz, CA), p21 Waf1/Cip1 (2947; Cell Signaling), phospho-
ATM (Ser1981; 2152-1; Epitomics, Burlingame, CA), phospho-Chk2 (Thr68;
2661; Cell Signaling), and phospho-Chk1 (Ser295; 2349; Cell Signaling). Band
intensities on the Western blots were quantified by densitometry using the
ImageJ software. Relative total Chk1 levels were normalized to corresponding
-actin levels. Subsequently, Chk1 depletion efficiencies are given relative to
total Chk1 levels in control untreated cells.
RESULTS
Enhanced H2AX Formation in Chk1-depleted Cells
Treated with Replication Inhibitors Precedes Apoptosis
To determine the effect of Chk1 depletion on the induction
of H2AX phosphorylation after DNA replication stress,
HCT116 cells treated with control or Chk1 siRNAs were
exposed to thymidine or HU for up to 48 h. At various times
cell extracts were prepared from these cultures, and H2AX,
RPA34, and active caspase-3 were analyzed by Western
blotting. Cells treated with the control siRNA showed a
transient induction of H2AX at 16–24 h after treatment
with thymidine or HU (Figure 1, A and B). At later times
H2AX levels decreased before increasing again at 48 h
after treatment with replication inhibitor, most likely in
response to DNA fragmentation that occurs in some of the
cells (Rogakou et al., 2000). In Chk1-depleted cells this phos-
phorylation could be detected at about the same time (16 h)
but was distinctly stronger and more persistent. H2AX
accumulation coincided with the hyperphosphorylation of
RPA34 and occurred well in advance of caspase-3 activation.
The high level of H2AX in Chk1-depleted cells treated with
replication inhibitors was not limited to HCT116 as SW480
and MRC5 cells depleted of Chk1 showed a similar induc-
tion of H2AX and RPA34 phosphorylation after thymidine
treatment (Supplemental Figure S1, A and B). Additionally
enhanced levels of H2AX and RPA hyperphosphorylation
were detected after thymidine exposure of HCT116 cells
Figure 1. Induction of H2AX in Chk1-de-
pleted cells upon replication stress coincides
with RPA34 hyperphosphorylation and pre-
cedes apoptosis. Western blot analysis of
H2AX, RPA34, and cleaved caspase-3 in ex-
tracts obtained from HCT116 cells transfected
with control or Chk1 siRNAs treated or not
treated with 2 mM thymidine (TdR) (A) or 2 mM
hydroxyurea (HU; B) for the indicated times.
The band showing slower mobility on panel
probed with the RPA34 antibody represents hy-
perphosphorylated forms of the protein. (C)
Western blot analysis of H2AX and RPA34 in
extracts obtained from HCT116 cells transfected
with control or Chk1 siRNAs after a 24-h treat-
ment with 2 mM thymidine or exposure to 10 Gy
of IR. Cells exposed to IR were harvested 1 h
after treatment. -Actin levels are presented as
loading controls. The percent depletions of Chk1
for cultures treated with the Chk1 siRNAs are
presented. These values were normalized to the
-actin levels loading controls.
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treated with a Chk1 inhibitor (Gö6976) that has been shown
to mimic the effects of the Chk1 siRNA (Sidi et al., 2008;
Beckerman et al., 2009; Supplemental Figure S1C).
The level of H2AX accumulating in Chk1-depleted cells
treated with thymidine was clearly elevated relative to cells
exposed to IR (Figure 1C). Interestingly Chk1 status did not
affect the level of H2AX in IR-treated cells and RPA hyper-
phosphorylation was not detected in any of the cells exposed
to IR. The timing of H2AX phosphorylation in control or
Chk1-depleted cells exposed to IR was distinctly different
from that found in cells treated with replication inhibitors
(Supplemental Figure 2A). After a 10-Gy dose of IR, HCT116
cells showed a rapid but transient induction of H2AX phos-
phorylation detectable as early as 30 min after treatment that
persisted up to 2 h.
To further characterize the kinetics of H2AX phosphory-
lation during replication stress, we used flow cytometry to
measure the fraction of HCT116 cells containing H2AX and
DNA content. Consistent with the Western blots presented
above, 8% of HCT116 cells treated with the control siRNA
showed H2AX induction at 16 h after thymidine exposure
(Figure 2, A and B). In Chk1-depleted HCT116 cells treated
with thymidine a significantly higher proportion of cells
showed H2AX phosphorylation (35–60%) at 16–48 h of
exposure (Figure 2, A and C). This was not due to the
accumulation of cells in S-phase as there was no significant
difference in cell cycle distribution in cells treated with con-
trol or Chk1 siRNAs (Figure 2, B and C, middle panels).
PI staining revealed that, in the absence of Chk1, H2AX
accumulates in cells at the G1/S border and in S-phase at 16
to 24 h after thymidine treatment (Figure 2C, bottom panel).
After longer exposures to thymidine (30 and 48 h), H2AX
appears mainly in S-phase cells, coinciding with the move-
ment of the cell population into S-phase. In contrast, H2AX
phosphorylation in control cells was spread throughout all
phases of the cell cycle with the greatest density of positive
cells in G2/M after 48-h thymidine arrest (Figure 2B, bottom
panel).
The above FACS analysis also revealed the accumulation
of cells with a subG1 DNA content in Chk1-depleted cul-
tures after 30 h of thymidine treatment (Figure 2, A and C),
consistent with the detection of activated caspase-3 at this
time in the Western blots (Figure 1A). Because both of these
measures of apoptosis occurred much later than H2AX
induction, it seemed unlikely that the H2AX phosphospho-
rylation observed at early times was a result of the DNA
fragmentation that occurs as cells undergo apoptosis (Roga-
kou et al., 1999). Interestingly only a small proportion (7.9%)
of Chk1-depleted cells with a subG1 DNA content had an
increased level of H2AX after a 48-h thymidine treatment
(Figure 2C, top panels, UL). To further confirm the late onset
of apoptosis, we measured in vivo activation of caspase-3 in
a FACS-based assay and TUNEL cells under the above
conditions of replication stress. The fraction of cells with
active caspase-3 showed little change after thymidine treat-
ment of Chk1-depleted cells until 36 h, when a robust in-
crease was detected (Supplemental Figure S3A). There was
relatively little increase in the fraction of cells staining for
active caspase-3 after treatment with the control siRNA or in
cells treated with either siRNA in the absence of thymidine.
Similarly there was a significant increase in the fraction of
TUNEL cells in Chk1-depleted HCT116 cultures treated
with thymidine at 48 h (Supplemental Figure S3B). Thus the
induction of H2AX formation significantly preceded the
onset of apoptosis.
H2AX and RPA Foci Colocalize in Chk1-depleted Cells
Treated with Thymidine
Given the localization of H2AX to foci at sites of damage
after IR, we next investigated the nuclear organization of
H2AX in Chk1-depleted cells treated with replication in-
hibitors.
In HCT116 cells treated with the control siRNA, low levels
of H2AX foci (1–10/cell) were detected after 6 h of thymi-
dine treatment, and the fraction of such cells continued to
increase through 24 h (Figure 3A and B). Cells with higher
levels of foci were less common at all times. In Chk1-de-
pleted cells, varying patterns of nuclear H2AX phosphory-
lation were detected after thymidine arrest (Figure 3, A and
B, Supplemental Figure S4). After a 6-h exposure some cells
stained weakly and had few foci (1–10 foci), whereas others
had widespread foci (10/cell) and more intense staining.
In addition a small fraction of cells showed diffuse, bright
pan-nuclear staining (Figure 3A). This heterogeneity might
reflect a difference in staining in cells in early or late S-phase
(Cowell et al., 2007). The frequency of cells showing pan-
nuclear staining markedly increased after longer exposure
times (16 and 24 h) in the absence of Chk1. Cells with 10
foci also increased while those with 10 foci decreased at
24 h. A similar response was seen in HCT116 cells treated
with the Chk1 inhibitor Gö6976 (data not shown).
Immunofluorescence analysis was next performed to in-
vestigate the relationship between RPA foci that form in
Chk1-depleted cells treated with replication inhibitors (Ro-
driguez et al., 2008) and H2AX foci. At early times after
thymidine treatment when the foci were distinct (6 h, Figure
3B), 92% of cells with RPA and H2AX foci showed colocal-
ization, and 73% of the foci in these cells were colocalized.
However, RPA foci were detected before the appearance of
the H2AX foci. Cells that showed pan-nuclear staining of
H2AX also showed similar staining patterns for RPA.
We also determined the frequency of cells staining for
H2AX foci formation and TUNEL (Figure 3C). Although
53.4% of the Chk1-depleted cells showed H2AX foci after a
48-h thymidine treatment and 12.6% were TUNEL, only
3.6% stained for both. Thus the dramatic increase in H2AX
phosphorylation in Chk1-depleted cells preceded the onset
of apoptosis, but our results suggest that enhanced H2AX
is not an indicator of cellular commitment to apoptosis.
H2AX phosphorylation and foci formation occur tran-
siently in cells exposed to IR, and this has previously been
shown to reflect the time required to repair DSBs induced by
this agent (Rogakou et al., 1999). In control or Chk1 siRNA-
treated HCT116 cells, H2AX foci formed at 15–90 min after
IR exposure (Supplemental Figure S2, B and C). Interestingly
these radiation-induced H2AX foci do not colocalize with
RPA. Thus the kinetics of H2AX induction and localization
are distinctively different for Chk1-depleted cells exposed to
IR relative to those exposed to replication inhibitors.
Cdc45 Depletion Suppresses H2AX Phosphorylation and
the Formation of H2AX Foci in Chk1-depleted Cells
Treated with Replication Inhibitors
We previously reported that RPA foci and apoptosis in-
duced in Chk1-depleted cells treated with replication inhib-
itors could be suppressed by depletion of Cdc45 (Rodriguez
et al., 2008). To determine whether the induction of H2AX
was also suppressed under these conditions, HCT116 cells
were codepleted of Chk1 and Cdc45 and treated with thy-
midine for 24 or 48 h. Cells were then harvested and ana-
lyzed for H2AX and RPA34 by Western blotting, or cells
were fixed and stained for H2AX foci formation. We pre-
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viously showed that siRNA-mediated depletion of Cdc45
slightly slowed progression through S-phase but did not
significantly affect cell viability in colony forming assays or
induce apoptosis. Similarly Cdc45 depletion did not stimulate
H2AX phosphorylation or RPA34 hyperphosphorylation in
control or thymidine-treated cells (Figure 4A). However the
robust induction of H2AX and hyperphosphorylation of RPA
seen in the Chk1-depleted cells in the presence of thymidine
Figure 2. Kinetics of H2AX induction after thymidine treatment of HCT116 cells transfected with control or Chk1 siRNAs. (A) Percentages
(%) of H2AX positive cells or cells with subG1 DNA contents at indicated times of 2 mM thymidine (TdR)-treatment of siRNA-transfected
HCT116 cells, as measured by flow cytometry. Results in A represent the means of three independent experiments  SDs. (B and C) Scatter
plots presenting flow cytometric analysis of H2AX fluorescence intensity and PI staining in control (B) or Chk1 (C) siRNA-transfected cells
exposed to thymidine for the indicated times. Cell cycle profiles are also presented, below the corresponding H2AX assay, for either total
cells (middle panels) or cells gated for increased H2AX staining (upper right or UR) region in the plots, lower panels). Cells with a subG1
DNA content are boxed on the left of each panel with the H2AX-positive cells having a subG1 DNA content on the upper left (UL).
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were reduced to control levels in codepleted cells (Figure 4A).
Similar effects on H2AX formation and RPA hyperphospho-
rylation were seen in Chk1-depleted HCT116 cells treated with
a second Cdc45 siRNA and in cells treated with the Chk1
inhibitor Gö6976 instead of the siRNA (Supplemental Figure
S5, A and B). Cdc45 depletion also suppressed H2AX induc-
tion and RPA hyperphosphorylation in SW480 cells depleted
of Chk1 (Supplemental Figure S5C).
To confirm this, we next examined the nuclear distribu-
tion of H2AX in HCT116 cells transfected with control or
Chk1 siRNAs after a 24-h treatment with thymidine (Figure
4, B and C). During unperturbed DNA replication, depletion
of Cdc45 produced a low level of cells staining weakly (1–10
foci) for H2AX fluorescence relative to control or Chk1-
depleted cells that may reflect the slower progression
through S-phase seen in such cells. This increase was not as
pronounced in cells codepleted of Cdc45 and Chk1. After a
2-h exposure to thymidine, the percentages of Cdc45-de-
pleted cells with H2AX foci (weakly staining with 1–10 foci
or showing more intense staining with 10 foci) were
slightly higher than thymidine-treated control cells. Cells
with pan-nuclear staining were not detected. Chk1 ablation
dramatically increased the fraction of cells with 10 foci and
those showing pan-nuclear staining after thymidine treat-
ment. Codepletion of Chk1 and Cdc45 reduced the forma-
tion of H2AX nuclear foci in arrested cells but more dra-
matically reduced the fraction of cells with pan-nuclear
staining relative to cells treated with Chk1 siRNA. The pro-
portion of cells staining weakly for H2AX (10 foci) in-
creased in the codepleted cells relative to cells depleted of
Chk1 alone but remained at the level of the control.
We also used flow cytometry to measure H2AX and
DNA content in cells depleted of Chk1 and/or Cdc45. These
analyses showed that the H2AX-positive cells that were
lost after codepletion of Chk1 and Cdc45 and thymidine
treatment were mainly in S-phase (Supplemental Figure S6).
Collectively, the above data from immunofluorescence and
FACS analyses verified the suppressive effect of Cdc45 de-
pletion on the enhanced induction of H2AX during repli-
cation stress in the absence of Chk1. Moreover, they indicate
that the pan-nuclear distribution of H2AX occurring in
Chk1-depleted cells is particularly dependent on Cdc45
function during S-phase.
In contrast HCT116 cells deficient in p21, a negative reg-
ulator of replication origin firing, showed a more robust
H2AX induction after treatment with the Chk1 siRNA or
the Chk1 inhibitor Gö6976 and exposure to thymidine rela-
tive to p21/ cells (Figure 4D).
Chk1-depleted Cells Fail to Recover from
Thymidine-induced Arrest
To further investigate the role of H2AX in the Chk1 sup-
pressed pathway, we measured H2AX levels and foci in
control and Chk1-depleted cells released from thymidine
treatment. We first determined the reversibility of thymidine
treatment in control and Chk1-depleted HCT116 cells. DNA
content in such cells was measured by FACS after continu-
ous exposure to thymidine for 24, 32, 40, 48 or 64 h and in
cultures exposed to thymidine for 24 h and then released
into thymidine-free medium for 8, 16, 24 or 40 h. Control
cells continuously exposed to thymidine slowly traversed
S-phase and accumulated in G2 after 64-h exposure (Sup-
plemental Figure S7). When these cells were released from
thymidine after 24 h, they reentered the cell cycle and after
16 h showed a profile similar to that of untreated cells.
Chk1-depleted cells showed a similar slow transition
through S-phase in the presence of thymidine; however, by
40 h 27% of cells showed a subG1 DNA content, and fewer
cells remained in S and G2. In Chk1-depleted cultures re-
leased into thymidine-free medium after 24 h, many cells
failed to reenter the cell cycle and remained in S-phase, and
16 h after release 24% showed a subG1 DNA content, much
like the cultures continuously exposed to thymidine. Mea-
surements of activated caspase-3 together with DNA content
verified the apoptotic response of Chk1-depleted cells dur-
Figure 3. Nuclear distribution of H2AX and RPA34 in HCT116
cells transfected with control or Chk1 siRNAs after thymidine treat-
ment. (A) Percentages of HCT116 cells treated with the indicated
siRNAs presenting low (1–10 foci/cell) or high (10 foci/cell) levels
of H2AX foci or showing pan-nuclear staining after exposure to 2
mM thymidine (TdR) for the indicated times. Results represent the
means of three independent experiments  SDs. (B) Representative
immunofluorescence images reveal colocalization of H2AX and
RPA foci. Colocalization of H2AX (green) and RPA34 (red) ap-
pears as yellow in merged images. (C) HCT116 cells transfected
with control or Chk1 siRNAs and exposed to 2 mM thymidine for
the indicated times were stained for H2AX or TUNEL. Most of the
Chk1-depleted cells with strong H2AX staining after 48-h exposure
to thymidine were negative for TUNEL staining. TUNEL staining
was only observed in cells with clear signs of apoptotic nuclear
morphology. Cells were also DAPI stained for DNA (blue).
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ing recovery from a 24-h thymidine arrest (Supplemental
Figure S8). After Chk1 ablation, activation of caspase-3 was
detected in S-phase during and after replication stress (31
and 24% of total cells, respectively). In contrast, both control
and Chk1 siRNA-treated cells were able to reenter the cell
cycle after release from a shorter (6 h) treatment with thy-
midine (Supplemental Figure S9A) although after a 16-h
thymidine treatment the Chk1-depleted cells were largely
committed to apoptosis (Supplemental Figure S9B).
We then analyzed the ability of Chk1-depleted cells to
resume DNA synthesis after release from thymidine (Figure
5A). Chk1 depletion had little effect on BrdU incorporation
in the absence of replication stress, with 44% of cells treated
with the control siRNA and 39% of cells depleted of Chk1
incorporating BrdU in a 1-h pulse (Figure 5, B–D). To deter-
mine the effect of replication stress in such cells, control or
Chk1 siRNA-treated HCT116 cells were exposed to thymi-
dine for 24 h, before being shifted to thymidine-free medium
and pulsed with BrdU for 1 h and then left to cycle for 2, 4,
6, or 20 h in thymidine- and BrdU-free medium before
harvest for FACS analysis of DNA content and BrdU incor-
poration. In HCT116 cultures exposed to thymidine for 24 h
before release, BrdU incorporation was detected in 86% of
cells treated with the control siRNA and in 72% of Chk1-
depleted cells. In control cultures the BrdU-positive cells
progressed through S-phase and after 6 h, 69% of them were
in G2. In the absence of Chk1, S-phase progression was
delayed in BrdU-labeled cells. By 6 h, only 33% progressed
to G2 phase. In cultures left to grow for 20 h after BrdU
labeling, control cells showed a more normal cell cycle dis-
tribution, with 45% of the BrdU-labeled cells traversing the
cell cycle to G1. In contrast a smaller proportion of BrdU-
labeled Chk1-depleted cells appeared in G1 (22%), whereas
most remained in S and G2. In addition nearly 20% of cells
from these cultures had a subG1 DNA content. Thus Chk1-
depleted cells show a strongly reduced capacity to reenter
and traverse S-phase and a greater commitment to death
after a 24-h exposure to thymidine, relative to control cells.
A high proportion of Chk1-depleted cells incorporate BrdU
after release but, given the reduced transition through S-
phase, this may not represent the resumption of synthesis at
stalled forks in some of these cells.
SW480 cells show a similar ability to rapidly reenter S-
phase after thymidine or HU treatment (Supplemental Fig-
ure S10, A and B). On release from thymidine a high pro-
portion incorporate BrdU in a 1-h pulse. By 4 h most of these
cells traversed S-phase and entered G2, and by 24 h a cell
cycle profile typical for growing cells is restored. For Chk1-
depleted SW480 cells, a much smaller proportion reenter
S-phase. Strikingly, a large number of cells with an S-phase
DNA content fail to incorporate BrdU in the 1-h pulse. By 4 h
after release there is very little change in the cell cycle
profile, and only a small proportion of the cells incorporat-
ing BrdU appear to have progressed to G2, and by 24 h after
release there is still little change in the cell cycle profile
suggesting that only a fraction of the cells incorporating
Figure 4. Cdc45 and p21 are effectors of the
enhanced induction of H2AX phosphorylation
or the formation of H2AX foci during DNA
replication stress in the absence of Chk1. (A)
Western blot analysis of H2AX and RPA34 in
extracts obtained from HCT116 cells trans-
fected with the indicated siRNAs and treated
or not treated with 2 mM thymidine for 48 h.
The levels of Chk1 and Cdc45 proteins in the
cells also are presented, whereas -actin levels
are presented as loading controls. (B) Percent-
ages of HCT116 cells treated with the indicated
siRNAs presenting low (1–10 foci/cell) or high
(10 foci/cell) levels of H2AX foci or pan-
nuclear staining after exposure to 2 mM thy-
midine for 24 h. Results represent the means of
three independent experiments  SDs. (C)
Representative images of H2AX immuno-
staining of HCT116 cells treated with the indi-
cated siRNAs after a 24-h thymidine arrest. (D)
Western blot analysis of H2AX and RPA34 in
extracts prepared from p21/ or p21/
HCT116 cells treated with control or Chk1
siRNAs or the Chk1 inhibitor Gö6976 and ex-
posed or not exposed to 2 mM thymidine for
24 h. The band showing slower mobility on
panel probed with the RPA34 antibody repre-
sents hyperphosphorylated forms of the pro-
tein. The levels of Chk1 in the cells treated
with the indicated siRNAs are presented.
Phosphorylation of Chk1 at the Ser296 auto-
phosphorylation site was measured (lower
band) to determine the effectiveness of Gö6976
treatment. -actin levels are presented as load-
ing control.
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Figure 5. Chk1-depleted HCT116 cells released from thymidine treatment remain committed to apoptosis and show suppressed reentry into
S-phase. (A) HCT116 cells transfected with control or Chk1 siRNAs and exposed to 2 mM thymidine for 24 h were washed (W) with
thymidine-free medium and transferred to medium containing 10 M BrdU. After 1 h these cells were washed with BrdU-free medium and
harvested for FACS analysis at the indicated times. (B and C) Representative scatter plots (top panels) show BrdU incorporation and DNA
content (PI staining) in cells transfected with control (B) or Chk1 siRNAs (C) as described above. Cells incorporating BrdU have been gated
(as indicated) to determine the percentages with G1, S, or G2 DNA content. Cells with a G1 DNA content incorporating BrdU at early times
after the pulse most likely represent cells at the G1/S border, although at 20 h these are likely to represent cells that have traversed the cell
cycle and reentered G1. Bottom panels present DNA content (PI staining) of all the cells in the cultures (gated and ungated). Cells indicated
as untreated present BrdU incorporation of cells before thymidine treatment. (D) Table summarizing the cell cycle distributions and total cells
incorporating BrdU treated as described in B and C. Results represent the means of three independent experiments  SDs.
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BrdU have resumed growth. SW480 cells released from HU
show a slower reentry into S-phase. At 4 h the cells largely
remain in S-phase and 40% are in G2 at 24 h. In Chk1-
depleted SW480 cells only 15–16% incorporate BrdU after
the 24-h exposure to HU and the cell cycle profile is largely
unchanged over 24 h. Thus like HCT116 cells, Chk1-de-
pleted SW480 cells show a strongly reduced ability to reen-
ter and traverse S-phase after release from treatment with
replication inhibitors.
H2AX Foci Persist in Chk1-depleted Cells Released from
Replication Stress
We next examined H2AX status in cells released from
thymidine treatment. HCT116 cells transfected with control
or Chk1 siRNAs and exposed to thymidine for 24 h were
released into thymidine-free medium or left to grow in the
inhibitor for another 24 h before harvest. Western blot anal-
ysis of total protein extracts from the above cultures showed
a decrease in the level of H2AX in Chk1-depleted cells
released from thymidine although it remained considerably
higher than in control cells treated with thymidine. Hyper-
phosphorylated RPA34 showed a gradual decline and was
barely detectable at 24 h after release (Figure 6A). This is
accompanied by a sustained activation of ATM (in the form
of pSer1981 ATM) and Chk2 (pThr68 Chk2) in the thymi-
dine-released cells. A similar pattern of sustained activation
of H2AX, ATM, and Chk2 were also found in Chk1-depleted
HCT116 cells treated with HU for 24 h and then released
(data not presented) and in SW480 cells treated with thymi-
dine or HU for 24 h and then released (Supplemental Figure
S11A).
In addition we measured H2AX foci in Chk1-depleted
cells recovering from thymidine arrest (Figure 6, B and C).
After release from a 24-h thymidine treatment the fraction of
cells showing 10 H2AX foci decreased slightly, whereas
there was a larger fall in the fraction of cells showing pan-
nuclear H2AX staining. We further measured the levels of
H2AX accumulation in Chk1-depleted HCT116 cells to-
gether with DNA content by flow cytometry as described
above (Figure 6D). This analysis revealed that the fraction of
cells positive for H2AX showed a progressive decline at 24
and 40 h after release relative to the fraction measured
before release (Figure 6, D and E), whereas only a small
proportion of control cells showed H2AX under the same
conditions. Interestingly only a very small proportion of
cells staining for increased H2AX (0.39–0.55%) had a
subG1 DNA content at 24 or 40 h after release even though
the percentage of total cells in these cultures with a subG1
DNA content was significantly higher at these times relative
to the Chk1-depleted cells treated with thymidine for 24 h
(Figure 6, D and E). Chk1-depleted SW480 cells produced
similar results with respect to H2AX foci after thymidine
treatment (Supplemental Figure S11, B and C) and FACS-
based analysis of H2AX levels after thymidine or HU (Sup-
plemental Figure S11D). Taken together these data indicate
that H2AX persists in a high proportion of Chk1-depleted
cells released from thymidine, although our data indicate
that some dephosphorylation of H2AX and loss of foci
occurs in these cells. Furthermore, cells containing elevated
levels of H2AX have a low level of apoptosis.
Most of the cells having increased H2AX after exposure
to thymidine for 24 h had a G1/S-phase DNA content,
whereas the cells released from thymidine for 24 h showed
a broader distribution (Figure 6D). This is similar to our
previous observation that Chk1-depleted cells labeled with
BrdU showed a prolonged transition through S-phase after
release (Figure 5C). In view of the slow transition of H2AX-
positive cells through S-phase during recovery from thymi-
dine arrest in the absence of Chk1 despite the incorporation
of BrdU in a high proportion of cells in these cultures, we
next examined BrdU incorporation in cells containing
H2AX foci by immunofluorescence. In Chk1-depleted cul-
tures treated with thymidine for 16 h and then released into
thymidine-free medium containing BrdU, only 16% of total
cells stained for both H2AX and BrdU incorporation (Fig-
ure 7, A and B). Strikingly, BrdU incorporation was detected
in only 35% of all cells showing H2AX foci and not at sites
of these foci (Figure 7A and B). Additionally, 54% of cells
showed BrdU incorporation but no H2AX foci and 30%
showed only H2AX foci.
Very similar responses were found with Chk1-depleted
SW480 cells (Figure 7C). Only 19% of Chk1-depleted cells
showed both H2AX foci and BrdU incorporation and, as
with HCT116 cells, BrdU incorporation was not detected at
sites of H2AX foci. As found previously a lower percentage
of Chk1-depleted SW480 cells incorporated BrdU after re-
lease from thymidine.
Similarly RPA foci found in Chk1-depleted HCT116 cells
after 16-h thymidine treatment and release into medium
containing BrdU do not colocalize with sites of BrdU incor-
poration (Figure 7D). However consistent with earlier re-
sults, the RPA foci detected in these experiments show a
high level of colocalization with H2AX foci (Figure 7E).
Cells Showing Persistent H2AX Are Less Likely to
Undergo Apoptosis
FACS analysis of H2AX levels and DNA content revealed
that cells with a subG1 DNA content did not contain en-
hanced levels of H2AX (Figure 6D). To further examine the
relationship between H2AX and the induction of death by
replication inhibitors in Chk1-depleted cells, we measured
caspase-3 activation in cells showing H2AX induction.
HCT116 cells treated with control or Chk1 siRNAs were
exposed to thymidine for 24 or 48 h or treated with thymi-
dine for 24 h and released into thymidine-free medium for
24 h before being fixed and stained for activated caspase-3,
H2AX, and DNA content by immunofluorescence analysis
as described above. Chk1-depleted cells showing activated
caspase-3 did not stain for H2AX, whereas those staining
for H2AX did not show activated caspase-3 (Figure 8A).
Taken together our data suggest that H2AX foci persist
at stalled forks in cells showing aberrant progression
through S-phase in the absence of Chk1. This is accompa-
nied by chronic activation of the ATM-mediated signaling
cascade but not the induction of apoptosis.
DISCUSSION
After the disruption of DNA replication cells rapidly acti-
vate both ATM and ATR-mediated signaling cascades to
protect the integrity of DNA (Zhou and Elledge, 2000; Bold-
erson et al., 2004). Work from several labs indicates that the
ATR-Chk1 pathway plays a critical role in protecting cells
from apoptosis under these conditions (Cho et al., 2005;
Rodriguez and Meuth, 2006; Xiao et al., 2005). H2AX for-
mation has normally been associated with the induction
DSBs after exposure to IR or other DNA-damaging agents
(Rogakou et al., 1998). However, a number of reports have
shown phosphorylation of H2AX after DNA replication
stress (Ward and Chen, 2001; Furuta et al., 2003; Ewald et al.,
2007) that is enhanced in Chk1-inhibited cells (Furuta et al.,
2006; Ewald et al., 2007). Given the association of this en-
hanced H2AX formation and cell death when Chk1 func-
tion is compromised, we further investigated the changes in
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H2AX phosphorylation in such cells during DNA replica-
tion stress. Here we show that H2AX phosphorylation and
foci formation occur well in advance of DNA fragmentation
or caspase-3 activation after the disruption of replication in
Figure 6. Persistence of H2AX and other DNA damage re-
sponse proteins in Chk1-depleted cells after release from thymi-
dine arrest. (A) Western blot analysis of H2AX, RPA34, phos-
pho-ATM (pSer1981), and phospho-Chk2 (pThr68) in extracts
obtained from HCT116 cells transfected with control or Chk1
siRNAs and treated or not treated with 2 mM thymidine (TdR)
for 24 h before release into thymidine-free medium for the
indicated times. The levels of Chk1 protein in the cells also are
presented, whereas -actin levels are presented as loading con-
trols. (B) Representative immunofluorescence images of H2AX
nuclear distribution in siRNA-transfected HCT116 cells treated
with thymidine for 24 h or treated and released from thymidine
for 24 h. (C) Percentages of HCT116 cells treated with control or
Chk1 siRNAs presenting low (1–10 foci/cell) or high (10 foci/
cell) levels of H2AX foci or showing pan-nuclear staining for H2AX during and after exposure to thymidine for the indicated times. Results
presented are the means of three independent experiments  SDs. (D) Representative scatter plots illustrating flow cytometric analysis of
H2AX levels and DNA content of siRNA-transfected HCT116 cells treated with 2 mM thymidine for 24 h and then released for 24 or 40 h
before harvest. H2AX cells with subG1, G1, S, or G2 DNA contents are gated. H2AX cells having a subG1 DNA content are in the top
left boxes, whereas the total cells with a subG1 DNA content are present in the top left and bottom left boxes. The table summarizes the cell
cycle distributions of the H2AX cells and the total cells with a subG1 DNA content. Values represent the means of three independent
experiments  SDs. (E) Percentages (%) of H2AX cells, H2AX cells with a subG1 DNA content, and total cells with a subG1 DNA
content in siRNA-transfected HCT116 cultures as measured by flow cytometry in D. Results represent the means of three independent
experiments  SDs.
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the absence of Chk1 in two colon cancer cell lines. H2AX
foci largely colocalize with RPA foci that form in such cells
indicating that H2AX phosphorylation occurs at the site of
disrupted replication forks. The pan-nuclear staining of
H2AX occurring in a subset of Chk1-depleted cells is a
distinctive feature of this response. A similar pattern of
Figure 7. BrdU incorporation does not coincide with H2AX or RPA foci after release of Chk1-depleted HCT116 cells from thymidine. (A)
HCT116 or SW480 cells transfected with the Chk1 siRNA were treated or not treated with 2 mM thymidine (TdR) for 16 h before release into
thymidine-free medium containing 10 M BrdU for 1 h. Cells were fixed and stained for BrdU incorporation or H2AX, immunofluorescence
images of BrdU incorporation with H2AX distribution in HCT116 (B), or SW480 (C) cells treated as above. The adjacent graphs show the
percentages of Chk1-depleted cells showing H2AX or BrdU staining or both. Notably, BrdU incorporation was not detected at the sites of
H2AX foci in either cell line. (D) HCT116 cells treated as in A were stained for BrdU incorporation and RPA34. BrdU incorporation was not
detected at nuclear sites of RPA34 foci. (E) Representative immunofluorescence images showing colocalization of H2AX and RPA34 foci in
Chk1-depleted HCT116 cells treated with thymidine for 16 h before release as above.
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H2AX staining that is independent of DNA DSB formation
and dependent on nucleotide excision repair has previously
been observed with primary human fibroblasts after UV
irradiation (Marti et al., 2006). Here we show that this wide-
spread phosphorylation of H2AX is particularly dependent
on the function of the essential replication helicase cofactor
Cdc45 as there is a pronounced loss of cells showing pan-
nuclear staining after Cdc45 depletion. Because Cdc45 is a
component of a protein complex involved in DNA replica-
tion initiation in human cells (Bauerschmidt et al., 2007;
Aparicio et al., 2009), these observations suggest that the
widespread phosphorylation may be promoted by the inap-
propriate firing of late or cryptic origins dispersed through
the genome upon suppression of Chk1 function (Maya-
Mendoza et al., 2007). Consistent with this argument,
H2AX formation is enhanced in cells deficient in p21 that
negatively affects the G13S transition and origin firing
through inhibition of cyclin-dependent kinase (El-Deiry et
al., 1993; Xiong et al., 1993). Both Cdc45 and p21 also affect
replication elongation; however, the effects of these proteins
on apoptosis (Rodriguez et al., 2008) and H2AX formation
are only seen in cells depleted of Chk1 where inappropriate
origin firing occurs (Maya-Mendoza et al., 2007).
After release of Chk1-depleted cells from thymidine,
H2AX persists in a high proportion of cells. Because BrdU
incorporation does not occur at persistent H2AX foci, they
are unlikely to represent sites of fork rescue despite their
colocalization with RPA34. Therefore, we propose that these
H2AX foci represent sites of persistent unresolved or aban-
doned forks that may also trigger the ATM and Chk2 acti-
vation observed here. The nature of the lesions triggering
this chronic response is not clear. They are not likely to be
persistent DSBs as these are not detectable in Chk1-depleted
cells by pulsed field gel electrophoresis (Rodriguez et al.,
2008). Given the sensitivity of these pulsed field gels (40
breaks/cell as measured using cells exposed to low levels of
Figure 8. Cells with persistent H2AX foci do not contain activated caspase-3. (A) HCT116 transfected with control or Chk1 siRNAs were
exposed to 2 mM thymidine for the indicated times or exposed to thymidine for 24 h followed by a 24-h release into thymidine-free medium.
Cells were then fixed and stained for H2AX and active caspase-3. Cells staining for H2AX foci did not show activated caspase-3. Similarly
cells staining for caspase-3 (that also showed a nuclear structure characteristic of apoptotic cells) did not stain for H2AX. (B) Proposed model
for the role of H2AX in the Chk1 suppressed death pathway responding to DNA replication stress. ATR-mediated Chk1 activation is crucial
to maintain cell viability and genome stability upon replication stress, by regulating fork integrity, replication restart, and inappropriate
origin firing in response to replication inhibitors (RIs, left). In the absence of Chk1, the action of Cdc45 on origin firing and helicase unwinding
increases the level ssDNA in cells, triggering a caspase-3–dependent apoptotic pathway in S-phase cells (middle). The data presented here
suggest that H2AX formation is enhanced in Chk1-depleted cells in response to persistent stress at DNA replication forks that also leads
to prolonged ATM and Chk2 activation. The accumulation of H2AX is also dependent on Cdc45, but the signal triggering H2AX
phosphorylation is not clear (right). Our results suggest that H2AX may help protect some cells from apoptosis, perhaps through
maintaining S-phase checkpoints. However, H2AX phosphorylation does not appear to be sufficient for the restart of DNA replication in the
absence of Chk1 as DNA replication is not detected at sites of H2AX foci after release from the replication inhibitor.
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IR), we cannot eliminate the possibility that a low level of
breaks may be transiently produced at some stalled forks.
However, the large number of H2AX foci and pan-nuclear
staining seen in the Chk1-depleted cells treated with repli-
cation inhibitors indicate that such DSBs would not be wide-
spread at such sites. We speculate that the BrdU incorpora-
tion occurring at sites distinct from H2AX foci in such cells
may represent cryptic origins that were activated in the
absence of Chk1 and incorporate BrdU once the cells were
released from the replication inhibitor, although they may
also represent origins that have successfully restarted repli-
cation after dephosphorylation of H2AX.
Despite the persistence of H2AX foci in some cells, they
do not appear to be committed to apoptosis. Cells strongly
staining for H2AX do not have a subG1 DNA content, are
not TUNEL, and do not show activated caspase-3. When
Chk1-depleted cells are released from the replication inhib-
itor, a subset of cells remain committed to apoptosis. Those
showing persistent H2AX slowly traverse S-phase but do
not die. The persistent activation of ATM and its down-
stream target Chk2 seen under these conditions is likely to
contribute to the retarded progression through S-phase. The
kinetics of H2AX formation in response to replication stress
reported here adds to the complexity of its regulation and
suggests that H2AX may interfere with the ability of cells to
become committed to apoptosis in the absence of Chk1.
Reports that H2AX may be phosphorylated by multiple
kinases such as ATM, ATR, DNA-PK, or JNK (Ward and
Chen, 2001; Stiff et al., 2005; Lu et al., 2006) indicate that
H2AX can act as a transducer of multiple upstream events.
Therefore, H2AX may help integrate and coordinate many
of the early events after replication fork stalling with later
events such as repair (Paull et al., 2000; Xie et al., 2004) and
replication restart depending on the appropriate firing of
replication origins. However in the absence of Chk1 the
repair/restart function may be compromised (Figure 8B).
Chk1 then occupies a central role in the regulation of cell
death in response to replication inhibitors through its mul-
tiple roles in controlling replication restart and origin firing
during stress.
It is important to note that one of the cell lines used in
these experiments (HCT116) has been shown to carry a
mutation of Mre11 (Giannini et al., 2002) that compromises
the activation of Chk2 (Takemura et al., 2006) and ATM
(Wen et al., 2008) after some types of DNA replication stress.
However the second colon cancer cell line used in these
experiments (SW480) does not have a mutation of Mre11
and shows a more normal activation of the ATM signaling
cascade after replication stress. The similar responses ob-
tained here with the two different colon cancer cell lines is
consistent with previous work from our laboratory show-
ing that ATM, Chk2, Mre11, and NBS1 are not determi-
nants of the induction of cell death by replication inhibi-
tors (Rodriguez and Meuth, 2006; Myers et al., 2009). It is
intriguing that Chk1 depletion restores ATM and Chk2
activation in HCT116 cells during DNA replication stress.
We have previously proposed that cells defective in Mre11
function may be compromised in their ability to process
stressed DNA replication forks into forms that activate this
signaling pathway. We speculate that in the absence of Chk1
alternative intermediates (perhaps in the form of abandoned
forks) may be produced at stalled forks that activate this
signaling cascade.
There is increasing interest in the use of H2AX as a
biomarker for DNA damage in response to environmental
stress or the efficacy of therapeutic agents in cancer patients
(Bonner et al., 2008). The work reported here indicates that
H2AX can be an effective indicator of irreversible DNA
replication fork arrest but not apoptosis.
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